| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | +546.47% | $10.05 | $64.97 | 2023-10-18 - 2024-05-17 | Strong Buy |
Zenas Biopharma IncZBIO | +406.92% | $7.66 | $38.83 | 2025-02-04 - 2025-11-28 | Buy |
Insmed IncINSM | +175.86% | $28.75 | $79.31 | 2024-02-15 - 2025-02-14 | Buy |
Avidity Biosciences IncRNA | +144.21% | $29.36 | $71.70 | 2025-06-17 - 2025-11-28 | Buy |
Oruka Therapeutics IncORKA | +111.82% | $14.21 | $30.10 | 2025-02-04 - 2025-11-28 | Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verona Pharma PLCVRNA | 1 | Buy | $170.00 | +59.01% | Initiates Coverage On | 5 months ago |
Bridgebio Pharma IncBBIO | 1 | Buy | $49.00 | -31.95% | Initiates Coverage On | 5 months ago |
Avidity Biosciences IncRNA | 1 | Buy | $55.00 | -23.29% | Initiates Coverage On | 5 months ago |
Moonlake ImmunotherapeuticsMLTX | 1 | Buy | $61.00 | +344.28% | Upgrades | 6 months ago |
Intellia Therapeutics IncNTLA | 1 | Buy | $21.00 | +133.59% | Upgrades | 7 months ago |
Oruka Therapeutics IncORKA | 1 | Buy | $20.00 | -33.55% | Initiates Coverage On | 10 months ago |
Vera Therapeutics IncVERA | 1 | Buy | $49.00 | +45.19% | Initiates Coverage On | 10 months ago |
Zenas Biopharma IncZBIO | 1 | Buy | $19.00 | -51.07% | Initiates Coverage On | 10 months ago |
Argenx SeARGX | 1 | Buy | $697.00 | N/A | Upgrades | a year ago |
Celldex Therapeutics IncCLDX | 1 | Buy | $51.00 | N/A | Reiterates | a year ago |
Kymera Therapeutics IncKYMR | 1 | Buy | $65.00 | N/A | Upgrades | a year ago |
Roivant Sciences LtdROIV | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Immunovant IncIMVT | 1 | Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Insmed IncINSM | 1 | Buy | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Rapt Therapeutics IncRAPT | 2 | Buy | $312.00 | N/A | Initiates Coverage On | 2 years ago |
Alpine Immune Sciences IncALPN | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Affimed NvAFMDQ | 1 | Strong Buy | $60.00 | N/A | Assumes | 2 years ago |